GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,708,000 | -4.3% | 62,201 | -4.2% | 0.14% | +12.7% |
| Q1 2022 | $2,829,000 | -4.9% | 64,951 | -3.7% | 0.13% | -6.0% |
| Q4 2021 | $2,975,000 | +9.9% | 67,451 | -4.8% | 0.13% | +8.1% |
| Q3 2021 | $2,708,000 | -12.5% | 70,871 | -8.8% | 0.12% | -9.5% |
| Q2 2021 | $3,096,000 | +8.9% | 77,742 | -2.4% | 0.14% | +3.0% |
| Q1 2021 | $2,842,000 | -3.0% | 79,642 | +0.1% | 0.13% | -8.3% |
| Q4 2020 | $2,929,000 | -5.5% | 79,592 | -3.4% | 0.14% | -31.9% |
| Q3 2020 | $3,101,000 | +1.0% | 82,394 | +9.5% | 0.21% | +21.0% |
| Q2 2020 | $3,069,000 | +5.8% | 75,244 | -1.7% | 0.18% | -9.7% |
| Q1 2020 | $2,900,000 | -18.4% | 76,544 | +1.2% | 0.20% | +1.6% |
| Q4 2019 | $3,555,000 | +20.6% | 75,644 | +9.5% | 0.19% | +33.3% |
| Q3 2019 | $2,947,000 | +6.0% | 69,052 | -0.6% | 0.14% | +7.5% |
| Q2 2019 | $2,781,000 | -3.7% | 69,497 | +0.5% | 0.13% | -2.9% |
| Q1 2019 | $2,889,000 | +10.3% | 69,122 | +0.8% | 0.14% | 0.0% |
| Q4 2018 | $2,620,000 | -5.7% | 68,572 | -0.8% | 0.14% | +17.9% |
| Q3 2018 | $2,777,000 | +28.9% | 69,123 | +29.3% | 0.12% | +17.0% |
| Q2 2018 | $2,155,000 | +4.4% | 53,464 | +1.2% | 0.10% | -1.0% |
| Q1 2018 | $2,064,000 | +13.1% | 52,819 | +2.7% | 0.10% | +20.2% |
| Q4 2017 | $1,825,000 | -23.4% | 51,444 | -12.4% | 0.08% | -32.3% |
| Q3 2017 | $2,384,000 | -7.1% | 58,730 | -1.4% | 0.12% | -10.8% |
| Q2 2017 | $2,567,000 | +1.9% | 59,539 | -0.4% | 0.14% | +3.7% |
| Q1 2017 | $2,520,000 | +5.1% | 59,767 | -4.0% | 0.13% | +2.3% |
| Q4 2016 | $2,398,000 | -12.3% | 62,267 | -1.8% | 0.13% | -14.4% |
| Q3 2016 | $2,735,000 | +15.4% | 63,408 | +15.9% | 0.15% | +9.3% |
| Q2 2016 | $2,371,000 | – | 54,708 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |